HSK-55718

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameHSK-55718
Drug Alias NameHSK55718HSK-55718
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsAcute PainPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Haisi Shengnuo Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAbbVie Group Holdings LtdShanghai Haisi Shengnuo Pharmaceutical Technology Co LtdHaisco Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute PainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A